Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor
Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor
Effective use of ibrutinib in the treatment of ABC lymphoma tumours
New drug demonstrates early promise in metastatic breast cancer
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475
Study shows benefits in use of AG-221 in advanced blood cancers
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment
Promising research on the use of palbociclib in the treatment of breast cancer
Role of genomics in assessing risk, especially in ovarian cancer
Coffee as a preventative measure against liver cancer
The relationship between obesity and cancer, and other dietary factors
ecancermedicalscience Editor's Choice for April 2014
Targeted Anti-cancer Therapies (TAT) conference roundup